Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( LIGHT 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
用户OtE-E_b2SQZ0
1个月前
99
10
已完结
1. 系统已在2026-05-01 16:48:32对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1111/dom.70429
文献链接: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70429
其他信息:
出版社: Wiley
作者: Fei Gao; Mingxia Yuan; Nianrong Mi; Danfeng Peng; Ruihua Dong; Wenjun Hu; Xiaolin Dong; Jingcheng Chen; Yulong Xu; Jian Zhou; Yuqian Bao; Qinghua Wang; Weiping Jia
全文下载地址: https://dom-pubs.pericles-prod.literatumonline.com/doi/pdf/10.1111/dom.70429
